HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subhra Mohapatra Selected Research

Prostatic Neoplasms (Prostate Cancer)

9/2013Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents.
5/2011Natriuretic peptide receptor a as a novel target for prostate cancer.
3/2009Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors.
9/2005Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Subhra Mohapatra Research Topics

Disease

21Neoplasms (Cancer)
11/2023 - 01/2008
9Infections
01/2023 - 01/2012
9Inflammation (Inflammations)
10/2020 - 02/2008
7Respiratory Syncytial Virus Infections
01/2023 - 01/2005
6COVID-19
12/2022 - 01/2021
5Lung Neoplasms (Lung Cancer)
11/2023 - 09/2013
5Traumatic Brain Injuries (Traumatic Brain Injury)
10/2020 - 10/2011
4Pneumonia (Pneumonitis)
01/2023 - 01/2008
4Neuroinflammatory Diseases
01/2022 - 05/2019
4Prostatic Neoplasms (Prostate Cancer)
09/2013 - 09/2005
3Virus Diseases (Viral Diseases)
12/2022 - 05/2014
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2018
3Neoplasm Metastasis (Metastasis)
10/2019 - 01/2008
3Asthma (Bronchial Asthma)
06/2011 - 02/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 06/2023
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2023 - 01/2005
2Hyperoxia
05/2018 - 01/2018
2HIV Infections (HIV Infection)
01/2015 - 01/2012
2Carcinogenesis
07/2013 - 01/2008
1Pain (Aches)
10/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Memory Disorders (Memory Loss)
01/2022
1Bacteremia
05/2021
1Hypersensitivity (Allergy)
01/2021
1Colonic Neoplasms (Colon Cancer)
11/2020
1Atopic Dermatitis (Atopic Eczema)
01/2020
1Epilepsy (Aura)
10/2019
1Arthritis (Polyarthritis)
10/2019
1Critical Illness (Critically Ill)
05/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2018

Drug/Important Bio-Agent (IBA)

9CytokinesIBA
01/2023 - 02/2008
6Atrial Natriuretic Factor (ANF)IBA
07/2013 - 01/2008
5ChitosanIBA
10/2014 - 02/2008
5atrial natriuretic factor receptor AIBA
07/2013 - 01/2008
4Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2012
4Antiviral Agents (Antivirals)IBA
01/2023 - 01/2005
4Peptides (Polypeptides)IBA
02/2021 - 01/2008
4Hormones (Hormone)IBA
07/2013 - 01/2011
4Natriuretic PeptidesIBA
05/2011 - 01/2008
3RNA (Ribonucleic Acid)IBA
11/2023 - 01/2008
3Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2018
3MicellesIBA
10/2017 - 10/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017 - 09/2013
3Small Interfering RNA (siRNA)IBA
01/2015 - 01/2005
3Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2009 - 09/2005
3RoscovitineIBA
03/2009 - 12/2003
2Tyrosine Kinase InhibitorsIBA
11/2023 - 02/2020
2ErbB Receptors (EGF Receptor)IBA
11/2023 - 02/2020
2Immune Checkpoint InhibitorsIBA
06/2023 - 01/2021
2withaferin AIBA
06/2023 - 10/2019
2Complement System Proteins (Complement)IBA
12/2022 - 01/2021
2posaconazoleFDA Link
11/2022 - 03/2022
2MicroRNAs (MicroRNA)IBA
01/2022 - 06/2011
2Interleukin-4 (Interleukin 4)IBA
01/2021 - 02/2008
2mithramycin AIBA
01/2021 - 10/2019
2LigandsIBA
01/2021 - 07/2013
2ChemokinesIBA
10/2020 - 01/2019
2Dactinomycin (Actinomycin)FDA LinkGeneric
12/2019 - 01/2017
2Oxygen (Dioxygen)IBA
05/2018 - 01/2018
2OsteopontinIBA
01/2018 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
10/2014 - 09/2013
2VaccinesIBA
01/2012 - 01/2005
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2023
1Acetates (Acetic Acid Esters)FDA Link
01/2023
1Liposomes (Liposome)IBA
01/2023
1InterferonsIBA
12/2022
1Opioid Analgesics (Opioids)IBA
10/2022
1CannabidiolIBA
10/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1PiperazineIBA
01/2022
1Butyrates (Butyrate)IBA
05/2021
1Glycoproteins (Glycoprotein)IBA
02/2021
1Nucleic Acid-Based VaccinesIBA
02/2021
1Angiotensin-Converting Enzyme 2IBA
02/2021
1Interleukin-13IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1Dendrimers (Dendrons)IBA
10/2020
1Ketoconazole (Nizoral)FDA LinkGeneric
02/2020
1CholesterolIBA
02/2020
1CateninsIBA
12/2019
1Telmisartan (Micardis)FDA Link
12/2019
1beta CateninIBA
12/2019
1Angiotensin Receptor AntagonistsIBA
12/2019
1Analgesics (Analgesic Drugs)IBA
10/2019
1Complex MixturesIBA
10/2019
1Calcibiotic Root Canal SealerIBA
10/2019
1amsonic acid (DAS)IBA
05/2019
1CC ChemokinesIBA
05/2019
1Culture MediaIBA
01/2019
1Pioglitazone (Actos)FDA Link
01/2019
1Ion Channels (Ion Channel)IBA
05/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2018

Therapy/Procedure

18Therapeutics
11/2023 - 02/2007
6Drug Therapy (Chemotherapy)
02/2020 - 12/2003
3Transplantation
10/2020 - 01/2019
2Immunotherapy
02/2021 - 01/2018
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2020 - 01/2020